TherapeuticsMD, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - February 23, 2018

Attached files

file filename
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc.ex32-2.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc.ex32-1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc.ex31-2.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc.ex31-1.htm
EX-21.1 - SUBSIDIARIES OF THE COMPANY - TherapeuticsMD, Inc.ex21-1.htm
10-K - ANNUAL REPORT - TherapeuticsMD, Inc.txmd-10k_123117.htm

 

 

TherapeuticsMD, Inc. 10-K

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our reports dated February 23, 2018, with respect to the consolidated financial statements and internal control over financial reporting included in the Annual Report of TherapeuticsMD, Inc. (a Nevada Corporation) on Form 10-K for the year ended December 31, 2017. We consent to the incorporation by reference of said reports in the Registration Statements of TherapeuticsMD, Inc. on Forms S-3 (File No. 333-207837, File No. 333-185156, and File No. 333-201171) and on Form S-8 (File No. 333-191730).

 /s/ GRANT THORNTON LLP

Fort Lauderdale, Florida

February 23, 2018

 

2

TherapeuticsMD, Inc. Reports